GMED vs INSP
As of Sep 20, 2026, Globus Medical (GMED) scores 4.4/10 and Inspire Medical Systems (INSP) 8.1/10 on AlphaStocks' five-model composite, so INSP scores higher. GMED trades 29% below its model fair value.
GMED
GLOBUS MEDICAL INC
4.4
Weak
$74.11
INSP
Inspire Medical Systems, Inc.
8.1
Strong Buy
$76.77
GMED vs INSP: Which is the Better Investment?
GLOBUS MEDICAL INC (GMED) scores 4.4/10 while Inspire Medical Systems, Inc. (INSP) scores 8.1/10 on AlphaStocks' composite model. Inspire Medical Systems, Inc. has the higher composite rating of Strong Buy. On a P/E basis, Inspire Medical Systems, Inc. trades at 15.7x, making it the more attractively priced of the two.
This comparison is algorithmically generated and is not financial advice.
| Metric | GMED | INSP |
|---|---|---|
| Scores & Fundamentals | ||
| Composite Score | 4.4/10 | 8.1/10▲ |
| Rating | Weak | Strong Buy▲ |
| Price | $74.11 | $76.77 |
| P/E Ratio | 18.9 | 15.7▲ |
| ROE | 12.0% | 15.5%▲ |
| Market Cap | $10B | $2B |
| Fair Value | $104.60 | — |
| Dividend Yield | — | — |
| Sector Rank | #130 of 168 | #1 of 168▲ |
| Model Verdicts | ||
| Piotroski | Strong▲ | Attractive |
| Buffett | Attractive | Attractive |
| Graham | Neutral | Neutral |
| Lynch | Neutral▲ | Limited Data |
| Greenblatt | Neutral▲ | Limited Data |
Related comparisons
GMED vs INSP: Which Stock Scores Higher?
GLOBUS MEDICAL INC (GMED) and Inspire Medical Systems, Inc. (INSP) are both in the Health Care sector. INSP currently leads with a composite score of 8.1/10 (Strong Buy) compared to GMED's 4.4/10 (Weak).
The AlphaStocks composite score evaluates each stock across four dimensions: Quality (business strength measured by Piotroski F-Score and Buffett quality criteria), Value (discount to intrinsic worth using Graham, Lynch, and Greenblatt models), Momentum (6-month price trend), and Timing (a confirmation signal that requires both value and momentum to align). A higher composite score indicates stronger overall fundamentals combined with favorable market conditions.
This comparison uses the same scoring framework for both companies, ensuring an apples-to-apples evaluation. Scores are recalculated daily after market close using data from SEC filings and market prices. Read the full methodology to understand how each model contributes to the composite score.
Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer